N-(2-Methoxy-5-(3-oxo-4-(3-(2-oxopyridin-1(2H)-yl)propyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)pyridin-3-yl)butane-1-sulfonamide

ID: ALA4244580

PubChem CID: 145983550

Max Phase: Preclinical

Molecular Formula: C26H30N4O6S

Molecular Weight: 526.62

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCS(=O)(=O)Nc1cc(-c2ccc3c(c2)N(CCCn2ccccc2=O)C(=O)CO3)cnc1OC

Standard InChI:  InChI=1S/C26H30N4O6S/c1-3-4-14-37(33,34)28-21-15-20(17-27-26(21)35-2)19-9-10-23-22(16-19)30(25(32)18-36-23)13-7-12-29-11-6-5-8-24(29)31/h5-6,8-11,15-17,28H,3-4,7,12-14,18H2,1-2H3

Standard InChI Key:  AHTCXGYECVWAPY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
   10.1571  -20.2441    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5698  -19.5383    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.7523  -19.5337    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5740  -21.1768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5740  -21.9940    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2792  -22.3985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9845  -21.9940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9845  -21.1768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2792  -20.7641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6912  -22.4070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6880  -23.2252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3911  -23.6347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3974  -21.9984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1049  -22.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0983  -23.2323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8011  -23.6457    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5150  -23.2438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5216  -22.4239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8143  -22.0060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2330  -22.0218    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2792  -19.9469    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8651  -20.7703    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1585  -21.1810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8198  -21.1888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5657  -18.7211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2713  -18.3089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2672  -17.4918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9728  -17.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5302  -20.7850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5357  -19.9678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2461  -19.5640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9532  -19.9826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6615  -19.5822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6712  -18.7647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9664  -18.3492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2519  -18.7512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9450  -20.7997    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10 11  1  0
 10 13  2  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
  7 10  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
  9 21  1  0
 21  2  1  0
  4 22  1  0
 22 23  1  0
 19 24  1  0
  2 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 24 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 31 36  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 32 37  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4244580

    ---

Associated Targets(Human)

SNU-638 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 526.62Molecular Weight (Monoisotopic): 526.1886AlogP: 3.28#Rotatable Bonds: 11
Polar Surface Area: 119.83Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.89CX Basic pKa: 0.79CX LogP: 1.46CX LogD: 1.36
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.41Np Likeness Score: -1.68

References

1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW..  (2018)  Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.,  26  (14): [PMID:29937355] [10.1016/j.bmc.2018.06.022]

Source